New UCLA Health study unveils blood test that can measure cumulative exposure over a lifetime
‘It is a recognition of the scholarly environment and infrastructure we have built to enable and foster outstanding scientific research,’ says David Geffen School of Medicine Dean Kelsey Martin
Research was led by UCLA Health's Dr. Leonid Kruglyak.
UCLA Health’s Dr. Ira Kurtz and collaborators are nearing the finish line in development of the groundbreaking device
UCLA Health needs volunteers for large trial investigating ways to reduce coronavirus hospitalizations and speed recovery
Specialists at UCLA Health have developed a system that allows for a quicker, more accurate diagnosis
Researchers have developed a breakthrough in cancer treatment known as chimeric antigen receptor (CAR) T-cell therapy. This promising form of immunotherapy attacks cancerous cells in the body. In 2017, the U.S. Food and Drug Administration (FDA) approved the first CAR T-cell treatments for patients with specific types of leukemia and lymphoma.
What is CAR T-cell therapy?